All News

6 key notes on chronic opioid therapy for workers compensation spinal fusions

By Laura Dyrda A new study published in Spine examines prescription opioid use after lumbar fusion for workers compensation patients. The study examined the CPT and ICD-9 codes for the Ohio WC patients who underwent lumbar fusion for degenerative disc disease from 1993 to

‘Floating’ plaque technique can provide additional spinal cord decompression

By Robert Linnehan Surgical techniques to treat thoracic ossification of the posterior longitudinal ligament vary in their outcomes, but evidence from a recently published study showed a posterolateral approach-based floating plaque technique was safe …

Osiris Therapeutics’s Buy Rating Reiterated at Piper Jaffray (OSIR)

Piper Jaffray restated their buy rating on shares of Osiris Therapeutics (NASDAQ:OSIR) in a research notereleased on Thursday morning, Market Beat reports. Piper Jaffray currently has a $28.00 price objective on the stock. A number of other equities research analysts have also commented on the

Greatbatch Receives Average Rating of “Buy” from Brokerages (NYSE:GB)

Greatbatch (NYSE:GB) has been assigned a consensus recommendation of “Buy” from the six analysts that are presently covering the stock, Market Beat.com reports. Two analysts have rated the stock with a hold recommendation and four have assigned a buy recommendation to the company.

Amplitude Surgical announces additional regulatory approvals in Australia

November 23, 2015 12:00 PM Eastern Standard Time VALENCE, France–(BUSINESS WIRE)–Regulatory News: Amplitude Surgical (Paris:AMPLI) (ISIN: FR0012789667, Ticker: AMPLI, PEA-PME eligible), a leading French player on the global surgical technology market for lower-limb orthopedics, today announces that it has been

Geriatric patients with ankle fracture show lower 1-year morbidity vs peers with other diagnoses

By Casey Tingle Geriatric patients with ankle fractures experienced lower 1-year morbidity compared with peers who sustained hip fractures or had an alternative admitting diagnosis, according to researchers of this study, even after they accounted for …

February 19, 2016: Orthopaedic and Rehabilitation Devices Panel of the Medical Devices Advisory Committee Meeting Announcement

Center Date Time Location CDRH February 19, 2016 8:00 a.m. – 6:00 p.m. Hilton Washington DC North Salons A, B, C, and D 620 Perry Pkwy. Gaithersburg, MD 20877 301–977–8900 DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration

Australia’s First 3D Printed Spine Implant

RMIT University in Melbourne has worked with a medical device company and a neurosurgeon to successfully create a 3D printed vertebral cage for a patient with severe back pain. When an abnormal structure of the fifth lumbar vertebra and severe

Arthroscopy may not accurately estimate glenoid bone loss in patients with shoulder instability

By Monica Jaramillo Investigators of this study found glenoid bone loss in patients with recurrent anterior shoulder instability is severely overestimated with the use of arthroscopy compared with 3-D CT scans. Researchers retrospectively reviewed info…

Dabigatran approved for DVT, PE prophylaxis after hip replacement surgery

Boehringer Ingelheim announced that the FDA has approved a new indication for dabigatran to prevent deep vein thrombosis or pulmonary embolism after hip replacement surgery. According to a press release issued by the company, DVT occurs in 40% to 60%

© 2025 MedDeviceJobs.com Powered by Careerleaf
v.4.6.1